Underweight MDLZ at 85-90% benchmark weight with $58.50 hard stop and pre-committed alpha-loss trim trigger
The neutral analyst's calibrated trim at 85-90% of benchmark with wider stop and pre-committed triggers is the cleanest synthesis — it addresses both the conservative's structural-floor concern (light trim, wider stop) and the aggressive's deterioration-cluster concern (directional reduction, defined downside exit). The 200 SMA at $58.93 has defended for 42+ sessions and the structural floor has not failed, so aggressive trimming into an intact floor (the 9/21 error) is not warranted. However, four consecutive Holds (9/22 through 9/25) produced sustained -0.87% average alpha bleed against SPY, and the 9/24 reflection is explicit: when the framework specifies an explicit trim trigger and price action prints exactly to that threshold, pre-committed action is mandatory. Underweight at 85-90% addresses the alpha economics without repeating the 9/21 error.
| Position | Action |
|---|---|
| Base case: 85-90% of consumer staples benchmark weight | Modest ~10-15% reduction from current levels |
| MDLZ underperforms SPY by -1.0% over any 5-session rolling window | AUTOMATICALLY trim an additional 5% into strength |
| Confirmed close <$58.50 on volume ≥10M | Further downgrade to Sell; trim residual aggressively toward 50% of benchmark |
MDLZ is a buy on weakness at the 58.93-60.20 zone, offering an asymmetric setup where technical support, margin recovery, premium innovation success, and income-oriented flow rotation all converge into a Q3 print targeting $66.65.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 61.19 | bearish |
| 50 SMA | 62.10 | bearish |
| 200 SMA | 58.93 | bullish |
| RSI | 39.65 | bearish |
| MACD Line | -0.42 | bearish |
| MACD Signal Line | -0.23 | bearish |
| MACD Histogram | -0.18 | bearish |
| Bollinger Upper Band | 63.18 | neutral |
| Bollinger Middle Band (20 SMA) | 61.69 | neutral |
| Bollinger Lower Band | 60.20 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Pullback to $58.50-$58.93 zone with RSI divergence and MACD histogram compressing toward zero
Then: Defensive add-on with stop at $58.00
EV: +$6.65 to $66.65 (52-week high) over 6-9 months from entry at 58.93-60.20 · concedes: Rising Treasury yields narrow the dividend-yield premium vs. fixed income alternatives; Higher-for-longer rate environment increases debt service costs incrementally; Consumer bargain-hunting is real in mass-tier products
MDLZ is not a buy at current levels because technical momentum is accelerating bearish, fundamentals show margin compression masked by pricing power (EBITDA down 6% YoY), leverage is rising to fund the dividend (77% FCF coverage), and the dividend yield has been outpaced by risk-free Treasuries, creating an asymmetric risk/reward to the downside.
· concedes: MDLZ is a quality franchise with real brand moat; Cocoa will eventually normalize; Margin recovery story is valid — eventually; 200 SMA is intact; long-term structure is fine
→ vs conservative: Structural bull case requires multiple favorable outcomes to converge simultaneously (cocoa stabilizing, volume holding, pricing power surviving, Q3 earnings confirming, 200 SMA holding) while bearish tactical evidence is already in motion and high-probability; waiting for 200 SMA break means position already down another 2 percent with materially worse short entry
→ vs neutral: Waiting for Q3 earnings (late October or early November) means voluntarily riding down a 2.2 percent air pocket if the 200 SMA breaks first; Q3 is a reaction event, not a tactical signal
→ vs neutral: HOLD is not a free option - every day in a name breaking down technically with expanding bearish momentum and deteriorating fundamentals incurs opportunity cost, drawdown cost if 200 SMA gives way, and psychological cost when eventually shaken out at worse levels
| ATR (14) |
| 1.20 |
| neutral |
Support: 60.2 · 58.93 · 57.79 | Resistance: 61.19 · 61.69 · 62.1 · 63.18
MDLZ exhibits two-way risk with short-term bearish signals conflicting with a structurally intact long-term uptrend. Price at 60.25 has broken below both the 10 EMA and 50 SMA while remaining above the rising 200 SMA at 58.93. Momentum is deteriorating with MACD histogram expanding negative (−0.18) and RSI approaching oversold territory at 39.65. Volatility compression (ATR at 1.20, Bollinger bands contracting) suggests an impending breakout catalyst. The tactical framework favors waiting for either a 10 EMA reclaim (61.19) for longs or 200 SMA breakdown (58.93) for shorts, with the 60.20 lower Bollinger Band serving as the immediate support pivot.
Market Capitalization
$76.81 B
P/E Ratio (TTM)
22.04
Forward P/E
17.90
PEG Ratio
0.89
Price / Book
2.89
EPS (TTM)
$2.73
Forward EPS
$3.36
Dividend Yield
3.45%
Beta
0.40
52-Week High
$66.65
52-Week Low
$51.20
50-Day Moving Average
$62.10
200-Day Moving Average
$59.48
Free Cash Flow (TTM)
$2.25 B
Free Cash Flow (FY2025)
$3.24 B
Free Cash Flow (FY2024)
$3.52 B
Free Cash Flow (FY2023)
$3.60 B
Free Cash Flow (FY2022)
$3.00 B
Revenue (TTM)
$39.67 B
Revenue (FY2025)
$38.54 B
Revenue (FY2024)
$36.44 B
Gross Profit (TTM)
$12.36 B
Gross Profit (FY2025)
$10.94 B
Gross Profit (FY2024)
$14.26 B
EBITDA (TTM)
$6.08 B
Net Income (TTM)
$3.52 B
Net Income (FY2025)
$2.45 B
Net Income (FY2024)
$4.61 B
Diluted EPS (FY2025)
$1.89
Diluted EPS (FY2024)
$3.42
Profit Margin
8.86%
Operating Margin
21.98%
ROE
13.34%
ROA
4.12%
Total Assets
$71.12 B
Cash & Equivalents
$1.52 B
Receivables
$5.38 B
Inventory
$4.08 B
Goodwill & Intangibles
$43.76 B
Net PP&E
$11.29 B
Total Liabilities
$45.32 B
Total Debt
$21.62 B
Net Debt
$19.50 B
Stockholders' Equity
$25.75 B
Current Ratio
0.60
Debt / Equity
82.6%
Goodwill
$24.2 B
Amortizable Intangibles
$19.5 B
Tangible Book Value
-$18.0 B
Operating Cash Flow (FY2025)
$4.51 B
Capital Expenditure (FY2025)
$1.28 B
Dividends Paid (FY2025)
$2.49 B
Buybacks (FY2025)
$2.39 B
Capital Return (FY2025)
$4.9 B
Q2 2026 Revenue
$10,080 M
Q2 2026 Gross Profit
$2,803 M
Q2 2026 EBITDA
$1,266 M
Q2 2026 Net Income
$560 M
Q2 2026 Diluted EPS
$1.20
Q1 2026 Revenue
$10,496 M
Q1 2026 Gross Profit
$2,956 M
Q1 2026 EBITDA
$1,425 M
Q1 2026 Net Income
$560 M
Q1 2026 Diluted EPS
$0.44
Q4 2025 Revenue
$10,496 M
Q4 2025 Net Income
$665 M
Q4 2025 Diluted EPS
$0.51
Q3 2025 Revenue
$9,744 M
Q3 2025 Net Income
$743 M
Q3 2025 Diluted EPS
$0.57
Q2 2025 Revenue
$8,984 M
Q2 2025 Gross Profit
$2,937 M
Q2 2025 EBITDA
$1,345 M
Q2 2025 Net Income
$641 M
Q2 2025 Diluted EPS
$0.49
Q1 2025 Revenue
$9,313 M
Q1 2025 Gross Profit
$2,430 M
Q1 2025 EBITDA
$1,006 M
Q1 2025 Net Income
$402 M
Q2 2026 Gross Margin
27.8%
Q2 2025 Gross Margin
32.7%
Q2 2026 EBITDA
$1.27 B
Q2 2025 EBITDA
$1.35 B
Revenue YoY (Q2 2026)
+12.2%
Revenue YoY (Q1 2026)
+12.7%
Share Count (2022)
~1,385 M
Share Count (Q2 2026)
~1,287 M
Quarterly Dividend
$0.46
Dividend Growth 2022-2025
+25%
Dividend / FCF Coverage
~77%
Buyback Rate
~$2.4 B/yr
Leverage / FCF
6.0x
Cost of Revenue (FY2024)
$22.2 B
Cost of Revenue (FY2025)
$27.6 B
Net Debt Change (FY2025)
+$2.13 B
Net Debt Change (FY2024)
-$1.23 B
Revenue (FY2023)
$36.02 B
Revenue (FY2022)
$31.50 B
Operating Income (FY2025)
$3.62 B
Operating Income (FY2024)
$6.67 B
Operating Income (FY2023)
$5.61 B
Operating Income (FY2022)
$3.80 B
Net Income (FY2023)
$4.96 B
Net Income (FY2022)
$2.72 B
Diluted EPS (FY2023)
$3.62
Diluted EPS (FY2022)
$1.96
Short-Term Debt + CP
$5.56 B
Long-Term Debt
$15.47 B
Sale of Business (2024)
~$2.3 B
Coffee Divestiture Gain
~$2.3 B
CapEx as % of Sales
~3%
Gross Margin Recovery Target
32–36%
100 bps Gross Margin Recovery
~$400 M
Organic Revenue Growth Guidance
Mid-to-high single-digit
Strengths
Concerns
Mondelez International operates as a globally dominant branded-snacks company with iconic franchises including Oreo and Cadbury, generating ~$3.2B in annual FCF and returning substantially all of it via dividends (3.45% yield) and buybacks (~7% share reduction since 2022). The 2025 cocoa price spike compressed margins (gross profit fell from $14.3B to $10.9B despite revenue growth), but 2026 shows recovery with Q2'26 gross margin at 27.8% trending toward the 32-36% target range and forward EPS of $3.36 implying ~23% growth. The balance sheet carries elevated leverage (net debt $19.5B at 6x FCF) and $43.8B in goodwill/intangibles (62% of assets), reflecting its brand-house identity, while the 0.40 Beta confirms its defensive equity characteristics suited for income-oriented and defensive-growth investors with a 12-24 month horizon.
Macro: Higher-for-longer interest rate backdrop with soft-landing consensus; Treasury yields climbing as investors digest global risks; AI/tech-tilted equity leadership ignoring defensive consumer names; record Halloween spending but with bargain-hunting dominating; UK recession probability rising (+5.5pp WoW to 10%); Polymarket pricing zero Fed rate cuts in 2026.